Publications
2026
Discovery of two structurally distinct classes of inhibitors targeting the nuclease MUS81 and enhancing efficacy of chemotherapy in cancer cells. Prochazkova, J.; Carbain, B.; Marini, V.; Nikulenkov, F.; Havel, S.; Akavaram, N.; Khirsariya, P.; Sisakova, A.; Cibulka, J.; Boudova, M.; Zacpalova, M.; Kalovska, M.; Rodrigues, J.; Daniel, L.; Brezovsky, J.; Azzalin, C.; Paruch, K.*; Krejci, L*
J. Med. Chem. 2026, accepted.